The first quarter of 2024 has concluded, leaving a landscape reshaped by evolving market dynamics, groundbreaking therapeutic advancements, and persistent…
Read More
OpenBench and Concept Life Sciences Forge Strategic Alliance to Revolutionize Early-Stage Drug Discovery with Fee-for-Success Model
A groundbreaking strategic partnership has been announced between OpenBench, a pioneer in AI-driven drug discovery, and Concept Life Sciences, a…
Read More
Gilead Sciences Finalizes $5 Billion Acquisition of Tubulis, Bolstering Oncology Pipeline with Advanced ADC Technology
Gilead Sciences has officially completed its acquisition of Tubulis, a prominent German biotechnology firm specializing in the development of next-generation…
Read More
Protecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma Innovation
Today’s pharmaceutical landscape is characterized by drug development programs that routinely span continents, involving distributed research teams, multinational clinical trial…
Read More
Europe Faces a Decade-High Surge in Sexually Transmitted Infections, Highlighting Urgent Need for Enhanced Prevention and Treatment Strategies
New data released by Europe’s leading infectious disease agency reveals a concerning decade-high surge in bacterial sexually transmitted infections (STIs),…
Read More
Top pharma companies set sustainability goals, but emissions are still increasing
The global healthcare industry stands as a significant contributor to the planet’s carbon footprint, accounting for an estimated 4.4% of…
Read More
Paradigm Health Launches SPIRE Platform to Revolutionize Post-Approval Oncology Research
The landscape of oncology therapeutics is rapidly evolving, with groundbreaking treatments continuously emerging and receiving regulatory approval. However, the journey…
Read More
CVC Capital Partners and Groupe Bruxelles Lambert Launch $12.4 Billion Takeover Bid for Recordati, Signaling Potential Shift to Private Ownership
One of Italy’s few remaining publicly traded large pharmaceutical companies, Recordati, is on the cusp of transitioning to private ownership…
Read More
Q&A: How 3PLs are navigating the latest pharma trends – Pharmaceutical Technology
The pharmaceutical logistics landscape is undergoing a profound transformation, moving beyond the traditional "store and ship" model to embrace comprehensive…
Read More
Chinese firms landed 6 of 26 major pharma deals in 16 months, worth $53 billion
Over the past 16 months, Chinese-domiciled biotechnology companies have emerged as significant players in the global pharmaceutical landscape, securing approximately…
Read MoreYOU MAY HAVE MISSED
